Form D · Biotechnology
Micron Biomedical, Inc.
Atlanta, GA · CIK 0001957384
Offering snapshot reported Dec 26, 2024 · SEC filing
- Reported sold
- $15M Offering amount: $16.2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 11, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 26, 2024 | Initial | $14,999,983 | No comparison | 3 | SEC filing |
| Apr 17, 2023 | Initial | $2,999,995 | No comparison | 1 | SEC filing |
| Dec 7, 2022 | Initial | $14,014,491 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-533277
Source: Form D, filed Dec 26, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Labeeb Abboud | Director |
| Brian Bernick | Director |
| Steve Damon | Director, Executive |
| Steven Damon | Director, Executive |
| Matthew Goldman | Director |
| Sebastien Henry | Executive |
| Idean Marvasty | Executive |
| Devin Mc Allister | Executive |
| Mark Prausnitz | Director |
| Henry Sebastien | Executive |
| Bas Van Buijtenen | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
575 Fourteenth Street, Nw Suite 100
Atlanta, GA, 30318
Atlanta, GA, 30318